Ameliorative effects of pentoxifylline on NOS induced by diabetes in rat kidney

References

• Roessner C, Paasch U, Kratzsch J, Glander HJ, Grunewald S. Sperm apoptosis signalling in diabetic men. Reprod Biomed Online. 2012;25:292–299.
   PubMed Web of Science ®Google Scholar
• Collins AJ, Foley RN, Herzog C, et al. US Renal Data System 2010 Annual Data Report. Am J Kidney Dis. 2011;57:e1–526. A8,
   PubMed Web of Science ®Google Scholar
• Turgut F, Bolton WK. Potential new therapeutic agents for diabetic kidney disease. Am J Kidney Dis. 2010;55:928–940.
   PubMed Web of Science ®Google Scholar
• Sonmez MF, Narin F, Akkus D, Turkmen AB. Melatonin and vitamin C ameliorate alcohol-induced oxidative stress and eNOS expression in rat kidney. Ren Fail. 2012;34:480–486.
   PubMed Web of Science ®Google Scholar
• Pollock JS, Pollock DM. Endothelin, nitric oxide, and reactive oxygen species in diabetic kidney disease. Contrib Nephrol. 2011;172:149–159.
   PubMed Web of Science ®Google Scholar
• Honing ML, Morrison PJ, Banga JD, Stroes ES, Rabelink TJ. Nitric oxide availability in Diabetes Mellitus. Diabetes Metab Rev. 1998;14:241–249.
   PubMed Web of Science ®Google Scholar
• Dellamea BS, Leitao CB, Friedman R, Canani LH. Nitric oxide system and diabetic nephropathy. Diabetol Metab Syndr. 2014;6:17. DOI: 10.1186/1758-5996-6-17.
   PubMed Web of Science ®Google Scholar
• Nasiri-Toosi Z, Dashti-Khavidaki S, Khalili H, Lessan-Pezeshki M. A review of the potential protective effects of pentoxifylline against drug-induced nephrotoxicity. Eur J Clin Pharmacol. 2013;69:1057–1073.
   PubMed Web of Science ®Google Scholar
• Stojiljkovic N, Veljkovic S, Mihailovic D, et al. Protective effects of pentoxifylline treatment on gentamicin-induced nephrotoxicity in rats. Ren Fail. 2009;31:54–61.
   PubMed Web of Science ®Google Scholar
• Navarro JF, Mora C, Muros M, Garcia J. Additive antiproteinuric effect of pentoxifylline in patients with type 2 diabetes under angiotensin II receptor blockade: A short-term, randomized, controlled trial. J Am Soc Nephrol. 2005;16:2119–2126.
   PubMed Web of Science ®Google Scholar
• Sonmez MF, Narin F, Akkus D, Ozdamar S. Effect of melatonin and vitamin C on expression of endothelial NOS in heart of chronic alcoholic rats. Toxicol Ind Health. 2009;25:385–393.
   PubMed Web of Science ®Google Scholar
• Bayatli F, Akkus D, Kilic E, Saraymen R, Sonmez MF. The protective effects of grape seed extract on MDA, AOPP, apoptosis and eNOS expression in testicular torsion: An experimental study. World J Urol. 2013;31:615–622.
   PubMed Web of Science ®Google Scholar
• Rahimi R, Nikfar S, Larijani B, Abdollahi M. A review on the role of antioxidants in the management of diabetes and its complications. Biomed Pharmacother. 2005;59:365–373.
   PubMed Web of Science ®Google Scholar
• Donder E, Dogan MM, Kuloglu T, Dabak ÖD, Kocaman N, Ozkan Y. The investigation of the effects of enalapril and losartan on ghrelin immunoreactivity in kidney of streptozotocin-induced diabetic rats. Fırat Tıp Dergisi. 2013;18:1–6.
   Google Scholar
• Usuelli V, La Rocca E. Novel therapeutic approaches for diabetic nephropathy and retinopathy. Pharmacol Res. 2015;98:39--44.
   PubMed Web of Science ®Google Scholar
• Yagihashi N, Nishida N, Seo HG, Taniguchi N, Yagihashi S. Expression of nitric oxide synthase in macula densa in streptozotocin diabetic rats. Diabetologia. 1996;39:793–799.
   PubMed Web of Science ®Google Scholar
• Yu WJ, Juang SW, Chin WT, Chi TC, Chang CJ, Cheng JT. Insulin restores neuronal nitric oxide synthase expression in streptozotocin-induced diabetic rats. Life Sci. 2000;68:625–634.
   PubMed Web of Science ®Google Scholar
• Shin SJ, Lai FJ, Wen JD, et al. Neuronal and endothelial nitric oxide synthase expression in outer medulla of streptozotocin-induced diabetic rat kidney. Diabetologia. 2000;43:649–659.
   PubMed Web of Science ®Google Scholar
• Komers R, Oyama TT, Chapman JG, Allison KM, Anderson S. Effects of systemic inhibition of neuronal nitric oxide synthase in diabetic rats. Hypertension. 2000;35:655–661.
   PubMed Web of Science ®Google Scholar
• Yabuki A, Tahara T, Taniguchi K, Matsumoto M, Suzuki S. Neuronal nitric oxide synthase and cyclooxygenase-2 in diabetic nephropathy of type 2 diabetic OLETF rats. Exp Anim. 2006;55:17–25.
   PubMed Web of Science ®Google Scholar
• Veelken R, Hilgers KF, Hartner A, Haas A, Bohmer KP, Sterzel RB. Nitric oxide synthase isoforms and glomerular hyperfiltration in early diabetic nephropathy. J Am Soc Nephrol. 2000;11:71–79.
   PubMed Web of Science ®Google Scholar
• Prabhakar S, Starnes J, Shi S, Lonis B, Tran R. Diabetic nephropathy is associated with oxidative stress and decreased renal nitric oxide production. J Am Soc Nephrol. 2007;18:2945–2952.
   PubMed Web of Science ®Google Scholar
• Xu J, Zou MH. Molecular insights and therapeutic targets for diabetic endothelial dysfunction. Circulation. 2009;120:1266–1286.
   PubMed Web of Science ®Google Scholar
• Prabhakar SS. Tetrahydrobiopterin reverses the inhibition of nitric oxide by high glucose in cultured murine mesangial cells. Am J Physiol Renal Physiol. 2001;281:F179–F188.
   PubMed Web of Science ®Google Scholar
• Schwartz D, Schwartz IF, Blantz RC. An analysis of renal nitric oxide contribution to hyperfiltration in diabetic rats. J Lab Clin Med. 2001;137:107–114.
   PubMed Web of Science ®Google Scholar
• Lee EY, Lee MY, Hong SW, Chung CH, Hong SY. Blockade of oxidative stress by vitamin C ameliorates albuminuria and renal sclerosis in experimental diabetic rats. Yonsei Med J. 2007;48:847–855.
   PubMed Web of Science ®Google Scholar
• Shan D, Wu HM, Yuan QY, Li J, Zhou RL, Liu GJ. Pentoxifylline for diabetic kidney disease. Cochrane Database Syst Rev. 2012;2:CD006800.
   PubMedGoogle Scholar
• Kim YK, Choi TR, Kwon CH, Kim JH, Woo JS, Jung JS. Beneficial effect of pentoxifylline on cisplatin-induced acute renal failure in rabbits. Ren Fail. 2003;25:909–922.
   PubMed Web of Science ®Google Scholar
• Akpolat T, Akpolat I, Ozturk H, et al. Effect of vitamin E and pentoxifylline on glycerol-induced acute renal failure. Nephron. 2000;84:243–247.
   PubMed Web of Science ®Google Scholar
• Brunner LJ, Vadiei K, Iyer LV, Luke DR. Prevention of cyclosporine-induced nephrotoxicity with pentoxifylline. Ren Fail. 1989;11:97–104.
   PubMed Web of Science ®Google Scholar
• Navarro JF, Milena FJ, Mora C, Leon C, Garcia J. Renal pro-inflammatory cytokine gene expression in diabetic nephropathy: Effect of angiotensin-converting enzyme inhibition and pentoxifylline administration. Am J Nephrol. 2006;26:562–570.
   PubMed Web of Science ®Google Scholar
• Navarro-Gonzalez JF, Muros M, Mora-Fernandez C, Herrera H, Meneses B, Garcia J. Pentoxifylline for renoprotection in diabetic nephropathy: The PREDIAN study. Rationale and basal results. J Diabetes Complications. 2011;25:314–319.
   PubMed Web of Science ®Google Scholar
• Badri S, Dashti-Khavidaki S, Lessan-Pezeshki M, Abdollahi M. A review of the potential benefits of pentoxifylline in diabetic and non-diabetic proteinuria. J Pharm Pharm Sci. 2011;14:128–137.
   PubMed Web of Science ®Google Scholar
• Garcia FA, Pinto SF, Cavalcante AF, et al. Pentoxifylline decreases glycemia levels and TNF-alpha, iNOS and COX-2 expressions in diabetic rat pancreas. Springerplus. 2014;3:283. DOI: 10.1186/2193-1801-3-283.
   PubMed Web of Science ®Google Scholar
• El-Bassossy HM, El-Moselhy MA, Mahmoud MF. Pentoxifylline alleviates vascular impairment in insulin resistance via TNF-α inhibition. Naunyn Schmiedebergs Arch Pharmacol. 2011;384:277–285.
   PubMed Web of Science ®Google Scholar
• Sun HK, Lee YM, Han KH, Kim HS, Ahn SH, Han SY. Phosphodiesterase inhibitor improves renal tubulointerstitial hypoxia of the diabetic rat kidney. Korean J Intern Med. 2012;27:163–170.
   PubMed Web of Science ®Google Scholar